Clinical Research Directory
Browse clinical research sites, groups, and studies.
Pharmacokinetics and Safety Profiles After Administration of DA-5221_01 and Co-administration of 5221_01-R1 and DA-5221_01-R2 in Healthy Adult Volunteers
Sponsor: Dong-A ST Co., Ltd.
Summary
Pharmacokinetics and Safety Profiles After Administration of DA-5221\_01 and Co-administration of 5221\_01-R1 and DA-5221\_01-R2 in Healthy Adult Volunteers
Official title: An Open-label, Randomized, Single-dose, 2-sequence, 2-period, Cross-over Study to Compare and Evaluate the Safety and Pharmacokinetic Characteristics After Single Administration of DA-5221_01 and Concomitant Administration of DA-5221_01-R1 and DA-5221_01-R2 Under Fasting Conditions in Healthy Adult Volunteers
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
44
Start Date
2024-09-30
Completion Date
2024-11-18
Last Updated
2024-09-27
Healthy Volunteers
Yes
Conditions
Interventions
DA-5221_01
single dose administration (DA-5221\_01 one tablet once a day)
DA-5221_01-R1 + DA-5221_01-R2
single dose administration (DA-5221\_01-R1 one tablet once a day + DA-5221\_01-R2 one tablet once a day)
Locations (1)
Bumin Hospital
Seoul, South Korea, South Korea